In recent years, vitamin D has received increased attention due to the resurgence of vitamin D deficiency and rickets in developed countries together with the identification of extraskeletal vitamin D receptor-mediated actions, suggesting unexpected benefits of vitamin D in health and diseases. Although there is increased awareness of the importance of vitamin D, the role of vitamin D in extraskeletal health has been a matter of debate. In this review, we will summarize what is known and indicate the questions that remain and need to be addressed. 
T
he importance of vitamin D for curing rickets has been known for over 80 yr. In recent years, there has been renewed interest in vitamin D because of its many other suggested roles in the skin, in the immune system, and in cancer prevention and treatment. This review will first briefly summarize the mechanisms by which vitamin D maintains calcium homeostasis followed by a consideration of the role of vitamin D in extraskeletal health.
Vitamin D and the Maintenance of Calcium Homeostasis
Vitamin D is important for the development and maintenance of bone as well as for the maintenance of normal calcium and phosphorus homeostasis (1) (2) (3) . The causal link between vitamin D deficiency during bone development and rickets and in adults between vitamin D deficiency and secondary hyperparathyroidism that can result in accelerated bone loss and increased risk of fracture is well documented (4, 5) . Vitamin D is synthesized in the skin from 7-dehydrocholesterol by UV irradiation. The synthesis of vitamin D in the skin, which is the most important source of vitamin D, depends of the intensity of UV irradiation, which varies with season and latitude (6) .
Although vitamin D can also be taken in the diet, few foods (which include fortified dairy products and fish oils) contain appreciable amounts of vitamin D. The hormonally active form of vitamin D, 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 (1, 2, 8, 9) . The phenotype of VDR knockout (KO) mice includes rickets, osteomalacia, and secondary hyperparathyroidism and thus represents a mouse model of vitamin D-dependent rickets type II (10 -13). When VDR KO mice are fed a diet high in calcium, phosphorus, and lactose, serum calcium and PTH are normalized and osteomalacia and rickets are prevented (14). These findings in the VDR KO mice suggest that a major defect from the loss of VDR activity is a defect in intestinal calcium and phosphate absorption, which is the primary cause of decreased bone mineralization. Thus, the principal function of vitamin in mineral homeostasis is to increase calcium and phosphorus absorption from the intestine. If normal serum calcium is unable to be maintained by intestinal absorption, increased PTH induces the synthesis of 1,25(OH) 2 
Extraskeletal Effects of Vitamin D
The possibility of extraskeletal effects of 1,25(OH) 2 D 3 was noted with the discovery in 1979 through the 1980s of the presence of VDR in tissues and cells that were not involved in maintaining calcium homeostasis, including pancreas, skin, placenta, brain, and activated T cells (1, (17) (18) (19) . VDR is not found in every cell or tissue (for example, VDR has been reported to be undetectable in striated and smooth muscle) (20, 21), supporting a role for VDR at specific extraskeletal sites. VDRs were also noted in a number of cancer cells, including breast, prostate, and colon cancer cells (22-25). When these cancer cells were incubated with 1,25(OH) 2 D 3 , their cellular proliferation was inhibited (24, 25). Leukemia cells were also found to express VDR, and when incubated with 1,25(OH) 2 D 3 , they differentiated to normal macrophages (26). In addition, in 1979, evidence of extrarenal 1␣(OH)ase was first found in placenta followed by the identification of 1␣ hydroxylation in macrophages (27, 28) . The question that remained was the biological significance of the presence of VDR and 1␣(OH)ase in different tissues.
Extrarenal 1␣(OH)ase

Monocytes/macrophages
It had been thought that the hypercalcemia and hypercalciuria in patients with sarcoidosis was due to enhanced responsiveness of the intestine to vitamin D. When elevated serum 1,25(OH) 2 D 3 occurred in a hypercalcemic anephric patient with sarcoidosis, this established an extrarenal site for the production of 1,25(OH) 2 D 3 (29) . Subsequently, it was demonstrated that macrophages from patients with sarcoidosis are the source of 1,25(OH) 2 D 3 and that monocyte/macrophage 1␣(OH)ase is regulated differently than renal 1␣(OH)ase [it is not suppressed by elevated 1,25(OH) 2 D 3 or calcium] (28, 30) . These findings indicated the in vivo significance of 1␣(OH)ase in macrophages and the mechanisms responsible for the hypercalcemia of granulomatous disorders.
Placenta
In placenta, 1␣(OH)ase is expressed in both fetal trophoblasts and maternal decidual cells beginning early in gestation (31) . Maternal killer cells from the decidua show decreased synthesis of cytokines, such as TNF and IL-6 in response to 1,25(OH) 2 D 3 , suggesting that 1,25(OH) 2 D 3 may act as an autocrine/paracrine regulator of immunity at the fetal-maternal interface (32) . Induction of the mRNA for cathelicidin, an antimicrobial peptide, by 1,25(OH) 2 D 3 in decidual cells has also been reported (33) . It has been suggested that the immunosuppressive effects of 1,25(OH) 2 D 3 allow for proper trophoblast invasion without a maternal immune response and thus for successful implantation (32) . Although the placenta was one of the first documented sources of extrarenal 1␣(OH)ase activity and 1,25(OH) 2 D 3 has been shown to modulate decidual immune cell function, the role of placental 1␣(OH)ase is speculative at this time. It is of interest, however, that in 1␣(OH)ase KO mice, in addition to rickets, reproductive and immune defects have been noted (34) , supporting the suggested role for 1,25(OH) 2 D 3 as an autocrine/paracrine regulator of immunity during pregnancy. Although it has been reported that 1,25(OH) 2 D 3 can be synthesized at sites other than kidney, macrophages, and placenta, the role of 1␣(OH)ase under normal conditions at other extrarenal sites has been a matter of debate.
The Role of VDR in Tissues Not Involved in Maintaining Calcium Homeostasis
VDR in cancer cells: Is there a role for vitamin D in cancer prevention and treatment?
In addition to the presence of VDR in cancer cells and the inhibition of proliferation by 1,25(OH) 2 (35) . In other in vivo studies using N-methyl-N-nitrosourea (NMU), an inhibition of the progression of mammary tumor growth is observed in rats treated with 1,25(OH) 2 D 3 or analogs of 1,25(OH) 2 D 3 after NMU treatment (36) . When rats are treated with 1,25(OH) 2 D 3 or analogs of 1,25(OH) 2 D 3 before treatment with NMU, tumor incidence is reduced or prevented (37) . In addition, the incidence of preneoplastic mammary lesions and the development of estrogen receptor negative tumors in response to DMBA is higher in VDR KO mice compared with wild-type mice (38) . In response to DMBA, VDR KO mice also display increased sensitivity to development of a variety of skin tumors and tumors in the lymph nodes (38, 39) . The studies in the VDR KO mice provide direct evidence in vivo that VDR ablation can enhance sensitivity to tumorigenesis. 1,25(OH) 2 D 3 has also been shown to delay the development of prostate interepithelial neoplasm in the Nkx3.1;Pten mutant mouse (a putative model for prostate carcinogenesis) (40) and to have tumor inhibitory activity in models of colorectal adenoma (41 
VDR in keratinocytes
Studies in keratinocytes indicated that 1,25(OH) 2 D 3 causes a marked decrease in proliferation and an increase in differentiation (45) . This led to the concept that 1,25(OH) 2 D 3 and/or its less calcemic analogs could be used to treat psoriasis. Topically applied, 1,25(OH) 2 
Vitamin D and the cardiovascular system
Studies in VDR KO mice and 1␣(OH)ase KO mice have shown that these mice develop hypertension and cardiac hypertrophy, which is associated with an increase in renin (47, 48) 
Vitamin D and the immune system
A role for vitamin D in the immune system was suggested by early studies indicating the presence of VDR in activated T cells (19). 1,25(OH) 2 D 3 inhibits lymphocyte proliferation and activation and IL-2 and interferon (IFN)␥ are decreased after activated T cells are exposed to 1,25(OH) 2 D 3 (51). 1,25(OH) 2 D 3 has also been shown to inhibit the differentiation and survival of dendritic cells, resulting in impaired alloreactive T cell activation (51) . The inhibition of maturation and differentiation of dendritic cells results in a decrease in IL-12 and an increase in IL-10 secretion (51). IL-17, which is involved in the pathogenesis of autoimmune inflammation and has been implicated in numerous autoimmune diseases, is inhibited by 1,25(OH) 2 
Innate immunity
Recent studies have suggested that vitamin D can also modulate innate immunity. 1,25(OH) 2 D 3 has been shown to induce the antimicrobial peptide cathelicidin with subsequent killing of bacteria, including mycobacterium tuberculosis (70) . Whether there is a beneficial effect of vitamin D in tuberculosis patients or a subset of tuberculosis patients remains to be determined.
Conclusion
The recent Institute of Medicine recommendation related to calcium and vitamin D supported their key role in skel- 
